Editor
LoD, Precision and PCR Performance Guide for Validation and Procurement
Interpret analytical sensitivity, repeatability, reproducibility, and evidence strength before using performance claims in validation or tenders.
Key takeaways
LoD, precision, and broader performance claims should be interpreted as part of a validation and procurement framework rather than as isolated headline numbers.
- Lower LoD does not automatically mean lower implementation risk.
- Precision should be reviewed across runs, operators, and sites where relevant.
- Analytical and clinical performance claims are not interchangeable.
- Evidence strength affects both tender confidence and validation burden.
Target audienceValidation teams, procurement reviewers, tender teams, distributors
Review and references
2026-10-01
2026-10-06
professional use
References
- IVDR performance evaluation references
- Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay. — Oncotarget, 2024 (PMID doi: 10.18632/oncotarget.28565)
- Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays. — Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020 (PMID doi: 10.1016/j.jcv.2020.104578)
FAQ
Common questions
What is the difference between LoD and clinical sensitivity?
LoD describes analytical detection threshold, while clinical sensitivity reflects how the assay performs in actual clinical or field-use contexts.
What is the difference between repeatability and reproducibility?
Repeatability focuses on consistency within the same operating conditions, while reproducibility reviews performance across broader variables such as operators, runs, or sites.
Why does Ct consistency matter in procurement review?
Ct consistency can indicate process stability and signal whether the workflow is likely to be easier or harder to validate and operate reliably.
What evidence should buyers request from suppliers?
Request clear validation summaries, sample context, compatibility details, precision data, and documentation that supports the intended use environment.
What it is
This topic explains how PCR performance claims should be read in operational context. Limit of detection, precision, repeatability, and reproducibility are useful, but only when matched to intended application and documentation quality.
Point 2
Buyers often over-focus on one metric. The stronger approach is to compare claim quality, validation burden, and implementation implications together.
Why it matters
Performance interpretation shapes validation scope, supplier comparison, and tender confidence. Weak interpretation can lead to overreliance on claims that do not transfer well into real laboratory conditions.
Point 2
This page links technical performance language to procurement and operational review criteria.
Workflow and evaluation steps
1
Separate claim types
Distinguish analytical sensitivity, precision, repeatability, reproducibility, and clinical performance before comparing suppliers.
2
Review evidence quality
Check whether performance claims are supported by usable documentation, sample context, and implementation relevance.
3
Estimate validation burden
Use claim quality and compatibility fit to estimate the practical effort needed before routine deployment.
Key comparison factors
- Sensitivity
- Sensitivity claims should be interpreted with intended use, sample matrix, and comparator context.
- Specificity
- Specificity and cross-reactivity evidence should be reviewed in practical testing scenarios.
- Ct Consistency
- Ct stability across runs can be relevant for monitoring consistency and operational confidence.
- Evidence Strength
- Better documentation can reduce implementation ambiguity and procurement risk.
Best-fit scenarios
Lab Validation
Use performance review to define what must be verified locally and what can be supported by supplier evidence.
Procurement Review
Performance claims help compare offerings only when supported by compatible documentation and workflow fit.
Tender Preparation
Clear understanding of claim quality helps procurement teams ask stronger technical questions.
Comparison matrix
Performance metric interpretation
| Metric | What it tells you | What it does not guarantee |
|---|---|---|
| LoD | Analytical detection threshold | Real-world workflow performance by itself |
| Repeatability | Within-condition consistency | Cross-site or cross-operator robustness |
| Reproducibility | Performance across broader conditions | Direct fit to every lab environment |
| Clinical performance | Use-context outcome relevance | Analytical detail for every workflow variable |
Compliance note
Performance statements should always be interpreted with intended use, sample context, and local verification requirements in mind. General claim summaries do not replace laboratory validation decisions.